Literature DB >> 19096810

[Multiple skin cancers in a patient treated with hydroxyurea].

A Wiechert1, G Reinhard, T Tüting, M Uerlich, T Bieber, J Wenzel.   

Abstract

A 62-year-old patient treated for 9 years with hydroxyurea for chronic myeloproliferative disease developed multiple cutaneous neoplasms. Hydroxyurea minimizes DNA synthesis via inhibition of the enzyme ribonucleotide reductase and is used to treat hematological malignancies. The most important and severe side-effect is a dose-dependent myelodepression. An association with multiple skin tumors has been reported. The presented case emphasizes this potential risk of hydroxyurea therapy. Continuous dermatologic monitoring of patients treated with hydroxyurea is recommended.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19096810     DOI: 10.1007/s00105-008-1673-1

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  12 in total

1.  The cutaneous side-effects of hydroxyurea.

Authors:  H S Young; A S Khan; J R Kendra; I H Coulson
Journal:  Clin Lab Haematol       Date:  2000-08

2.  Association of cutaneous side-effects of hydroxyurea and neuroendocrine carcinoma.

Authors:  Marie-Anne Bouldouyre; Marie-Françoise Avril; Alain Gaulier; Michèle Sigal-Grinberg
Journal:  Eur J Dermatol       Date:  2005 Jul-Aug       Impact factor: 3.328

3.  Skin cancer in immunosuppressed patients.

Authors:  J C Maize
Journal:  JAMA       Date:  1977-04-25       Impact factor: 56.272

4.  Inhibition of DNA repair in ultraviolet-irradiated human cells by hydroxyurea.

Authors:  A A Francis; R D Blevins; W L Carrier; D P Smith; J D Regan
Journal:  Biochim Biophys Acta       Date:  1979-07-26

5.  Cutaneous manifestations of long-term hydroxyurea therapy.

Authors:  R I Kelly; R H Bull; A Marsden
Journal:  Australas J Dermatol       Date:  1994       Impact factor: 2.875

Review 6.  Oral squamous cell carcinoma during long-term treatment with hydroxyurea.

Authors:  M De Benedittis; M Petruzzi; C Giardina; L Lo Muzio; G Favia; R Serpico
Journal:  Clin Exp Dermatol       Date:  2004-11       Impact factor: 3.470

7.  Metastatic squamous cell carcinoma of the skin in chronic myeloid leukaemia: complication of hydroxyurea therapy.

Authors:  G E Pamuk; B Turgut; O Vural; M Demir; M Tek; S Altaner
Journal:  Clin Lab Haematol       Date:  2003-10

8.  Clonal integration of a polyomavirus in human Merkel cell carcinoma.

Authors:  Huichen Feng; Masahiro Shuda; Yuan Chang; Patrick S Moore
Journal:  Science       Date:  2008-01-17       Impact factor: 47.728

Review 9.  Chronic myeloproliferative disorders.

Authors:  Jerry L Spivak; Giovanni Barosi; Gianni Tognoni; Tiziano Barbui; Guido Finazzi; Roberto Marchioli; Monia Marchetti
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2003

10.  Multiple squamous cell carcinomas of the skin during long-term treatment with hydroxyurea.

Authors:  C De Simone; C Guerriero; B Guidi; M Rotoli; A Venier; R Tartaglione
Journal:  Eur J Dermatol       Date:  1998-03       Impact factor: 3.328

View more
  2 in total

1.  Primary cutaneous undifferentiated round cell tumor with concurrent polymyositis in a dog.

Authors:  Paola Gianella; Giancarlo Avallone; Claudio Bellino; Selina Iussich; Chiara Palmieri; Paola Roccabianca; Claudia Salvadori; Renato Zanatta; Antonio D'Angelo
Journal:  Can Vet J       Date:  2012-05       Impact factor: 1.008

2.  Acquired melanonychia in chilean patients with essential thrombocythemia treated with hydroxyurea: a report of 7 clinical cases and review of the literature.

Authors:  Nigel P Murray; Pablo Tapia; Jose Porcell; Maximiliano Echavarria; Hernán Suazo
Journal:  ISRN Dermatol       Date:  2013-02-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.